Publications by authors named "Atul Bedi"

Claim this Profile
I
Immune profiles in primary squamous cell carcinoma of the head and neck.
Vassiliki Saloura, Evgeny Izumchenko, Zhixiang Zuo, Riyue Bao, Michael Korzinkin, Atul Bedi

Oral Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy.
Rajani Ravi, Kimberly A Noonan, Vui Pham, Rishi Bedi, Alex Zhavoronkov, Atul Bedi

Nat Commun· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.
Hiroyuki Ozawa, Ruchira S Ranaweera, Evgeny Izumchenko, Eugene Makarev, Alex Zhavoronkov, Atul Bedi

Clin Cancer Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
analysis of pathways activation landscape in oral squamous cell carcinoma and oral leukoplakia.
Eugene Makarev, Adrian D Schubert, Riya R Kanherkar, Nyall London, Mahder Teka, Atul Bedi

Cell Death Discov· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA.
Evgeny Izumchenko, Xiaofei Chang, Mariana Brait, Elana Fertig, Luciane T Kagohara, Atul Bedi

Nat Commun· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma.
Jill Gilbert, Michael J Schell, Xiuhua Zhao, Barbara Murphy, Tawee Tanvetyanon, Atul Bedi

Oral Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The TGFβ-miR200-MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors.
Evgeny Izumchenko, Xiaofei Chang, Christina Michailidi, Luciane Kagohara, Rajani Ravi, Atul Bedi

Cancer Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relative expression of Mig6 and EGFR is associated with resistance to EGFR kinase inhibitors.
Xiaofei Chang, Eugene Izumchenko, Luisa M Solis, Myoung Sook Kim, Aditi Chatterjee, Atul Bedi

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of TGF-β enhances the in vivo antitumor efficacy of EGF receptor-targeted therapy.
Atul Bedi, Xiaofei Chang, Kimberly Noonan, Vui Pham, Rishi Bedi

Mol Cancer Ther· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenylate kinase 3 sensitizes cells to cigarette smoke condensate vapor induced cisplatin resistance.
Xiaofei Chang, Rajani Ravi, Vui Pham, Atul Bedi, Aditi Chatterjee

PLoS One· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of p53 family member isoform DeltaNp63alpha by the nuclear factor-kappaB targeting kinase IkappaB kinase beta.
Aditi Chatterjee, Xiaofei Chang, Tanusree Sen, Rajani Ravi, Atul Bedi

Cancer Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signaling.
Rajani Ravi, Ephraim J Fuchs, Ajay Jain, Vui Pham, Kiyoshi Yoshimura, Atul Bedi

Cancer Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.
Rajani Ravi, Ajay J Jain, Richard D Schulick, Vui Pham, Traci S Prouser, Atul Bedi

Cancer Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NF-kappaB in cancer--a friend turned foe.
Rajani Ravi, Atul Bedi

Drug Resist Updat· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the TRAIL from death receptors to prostate cancer therapy.
Atul Bedi

Cancer Biol Ther· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential methods to circumvent blocks in apoptosis in lymphomas.
Rajani Ravi, Atul Bedi

Curr Opin Oncol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Rajani Ravi, Atul Bedi

Cancer Res· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L).
Rajani Ravi, Atul Bedi

Cancer Res· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis